NYSE:XYL • US98419M1009
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XYLEM INC (XYL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-11 | Stifel | Maintains | Buy -> Buy |
| 2026-02-11 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-11 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-26 | William Blair | Initiate | Outperform |
| 2026-01-07 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-05 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-05 | TD Cowen | Maintains | Hold -> Hold |
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-29 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-29 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-09 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-19 | Barclays | Initiate | Overweight |
| 2025-09-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-08-26 | TD Cowen | Maintains | Hold -> Hold |
| 2025-08-05 | UBS | Maintains | Buy -> Buy |
| 2025-08-01 | Stifel | Maintains | Buy -> Buy |
| 2025-07-21 | Stifel | Maintains | Buy -> Buy |
| 2025-07-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-30 | JP Morgan | Initiate | Overweight |
| 2025-04-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-30 | Stifel | Maintains | Buy -> Buy |
| 2025-04-30 | Baird | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.364B 33.36% | 8.562B 16.27% | 9.035B 5.52% | 9.295B 2.88% | 9.714B 4.51% | 10.231B 5.32% | 10.805B 5.61% | 11.777B 9.00% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 1.221B 37.66% | 1.633B 33.74% | 1.901B 16.41% | 2.142B 12.68% | 2.325B 8.54% | 2.514B 8.13% | 2.726B 8.43% | 2.857B 4.81% | N/A | N/A | N/A | |
| EBIT YoY % growth | 785M 20.58% | 1.071B 36.43% | 1.326B 23.81% | 1.75B 31.98% | 1.952B 11.54% | 2.092B 7.17% | 2.301B 9.99% | 2.33B 1.26% | 2.424B 4.03% | 2.521B 4.00% | 2.621B 3.97% | |
| Operating Margin | 10.66% | 12.51% | 14.68% | 18.83% | 20.09% | 20.45% | 21.30% | 19.78% | N/A | N/A | N/A | |
| EPS YoY % growth | 3.68 29.58% | 4.28 16.30% | 5.08 18.69% | 5.56 9.42% | 6.14 10.42% | 6.81 10.90% | 7.75 13.89% | 8.48 9.45% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.10 6.43% | 1.37 8.61% | 1.47 7.15% | 1.54 8.73% | 1.34 22.50% | 1.58 15.23% | 1.61 9.78% | 1.70 10.32% |
| Revenue Q2Q % growth | 2.133B 3.09% | 2.339B 1.65% | 2.358B 3.97% | 2.477B 3.34% | 2.302B 7.92% | 2.507B 7.18% | 2.46B 4.33% | 2.593B 4.68% |
| EBITDA Q2Q % growth | 441.86M 11.30% | 529.25M -14.77% | 558.81M -29.17% | 589.76M -38.63% | 522.81M 18.32% | 596.54M 12.71% | 606.07M 8.46% | 638.61M 8.28% |
| EBIT Q2Q % growth | 330.71M 31.23% | 417.73M 26.20% | 453.13M 26.93% | 478.19M 23.88% | 414.87M 25.45% | 510.87M 22.30% | 528.99M 16.74% | 543.3M 13.62% |
All data in USD
28 analysts have analysed XYL and the average price target is 160.09 USD. This implies a price increase of 32.92% is expected in the next year compared to the current price of 120.44.
XYLEM INC (XYL) will report earnings on 2026-04-27, before the market open.
The consensus EPS estimate for the next earnings of XYLEM INC (XYL) is 1.1 USD and the consensus revenue estimate is 2.13B USD.
The number of analysts covering XYLEM INC (XYL) is 28.